Lysine

Lysine

SCHEMBL5062299

NCCCC[C@H](N)C(=O)[O-].NCCCC[C@H](N)C(=O)[O-].[Fe+2]

nearest known ligand 0.61

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

PPARDPTGS1PTGS2dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Lysine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ GSR P00390 1/20 0.61
▸ RNPEP Q9H4A4 1/20 0.43
▸ GNAI3 P08754 1/20 0.43
▸ GNAO1 P09471 1/20 0.43
▸ GNAI1 P63096 1/20 0.43
▸ DPP7 Q9UHL4 9/20 0.42
▸ DPP8 Q6V1X1 5/20 0.42
▸ DPP9 Q86TI2 5/20 0.42
▸ DPP4 P27487 3/20 0.42
▸ CPB2 Q96IY4 2/20 0.39
▸ FAP Q12884 1/20 0.38
▸ MMP2 P08253 1/20 0.37
▸ ARG1 P05089 1/20 0.36
▸ ARG2 P78540 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lysine SCHEMBL5062296 1.00 GSR (0.61) GSRRNPEPGNAI3GNAO1GNAI1
Lysine SCHEMBL6444907 0.96 GSR (0.63) GSRRNPEPGNAI3GNAO1GNAI1
Lysine SCHEMBL5148145 0.95 GSR (0.61) GSRRNPEPGNAI3GNAO1GNAI1
Lysine SCHEMBL6037599 0.95 GSR (0.61) GSRRNPEPGNAI3GNAO1GNAI1
Lysine SCHEMBL4400353 0.95 GSR (0.61) GSRRNPEPGNAI3GNAO1GNAI1
Lysine SCHEMBL25283016 0.95 GSR (0.61) GSRRNPEPGNAI3GNAO1GNAI1
Lysine SCHEMBL3739868 0.95 GSR (0.61) GSRRNPEPGNAI3GNAO1GNAI1
Lysine SCHEMBL121844 0.95 GSR (0.61) GSRRNPEPGNAI3GNAO1GNAI1
Lysine SCHEMBL3517540 0.95 GSR (0.61) GSRRNPEPGNAI3GNAO1GNAI1
Lysine SCHEMBL3749535 0.95 GSR (0.61) GSRRNPEPGNAI3GNAO1GNAI1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3612542-B1 ENERGY-EFFICIENT SOLVENT-FREE METHOD FOR PRODUCING METAL CHELATES TECHNISCHE UNIV CLAUSTHAL (DE) 2026-04-22 — — EP claimed
US-12398157-B2 Energy-efficient solvent-free method for producing metal chelates TECHNISCHE UNIVERSITAT CLAUSTHAL (DE) 2025-08-26 — — US claimed
EP-4532464-A1 AGRICULTURALLY USEFUL MINERAL AMINO ACID COMPLEXES Statera Ag, LLC (US) 2025-04-09 — — EP claimed
WO-2023230428-A1 AGRICULTURALLY USEFUL MINERAL AMINO ACID COMPLEXES STATERA AG, LLC (US) 2023-11-30 — — WO claimed
US-20230219980-A1 ENERGY-EFFICIENT SOLVENT-FREE METHOD FOR PRODUCING METAL CHELATES TECHNISCHE UNIVERSITAT CLAUSTHAL (DE) 2023-07-13 — — US claimed
US-20260116846-A1 PREPARATION OF A LYSINATE COMPOUND FROM AN AQUEOUS LYSINE SOLUTION PHYTOBIOTICS FUTTERZUSATZSTOFFE GMBH (DE) 2026-04-30 — — US disclosed
US-12497350-B2 Preparation of a lysinate compound from an aqueous lysine solution PHYTOBIOTICS FUTTERZUSATZSTOFFE GMBH (DE) 2025-12-16 — — US disclosed
US-12398157-B2 Energy-efficient solvent-free method for producing metal chelates TECHNISCHE UNIVERSITAT CLAUSTHAL (DE) 2025-08-26 — — US disclosed
EP-4532464-A1 AGRICULTURALLY USEFUL MINERAL AMINO ACID COMPLEXES Statera Ag, LLC (US) 2025-04-09 — — EP disclosed
WO-2023230428-A1 AGRICULTURALLY USEFUL MINERAL AMINO ACID COMPLEXES STATERA AG, LLC (US) 2023-11-30 — — WO disclosed
US-20230219980-A1 ENERGY-EFFICIENT SOLVENT-FREE METHOD FOR PRODUCING METAL CHELATES TECHNISCHE UNIVERSITAT CLAUSTHAL (DE) 2023-07-13 — — US disclosed
EP-3670494-B1 PRODUCTION OF LYSINATE COMPOUND FROM AN AQUEOUS LYSIN SOLUTION PHYTOBIOTICS FUTTERZUSATZSTOFFE GMBH (DE) 2023-06-14 — — EP disclosed
US-11649252-B2 Energy-efficient solvent-free method for producing metal chelates TECHNISCHE UNIVERSITAT CLAUSTHAL (DE) 2023-05-16 — — US disclosed
US-20220024856-A1 PREPARATION OF A LYSINATE COMPOUND FROM AN AQUEOUS LYSIN SOLUTION PHYTOBIOTICS FUTTERZUSATZSTOFFE GMBH (DE) 2022-01-27 — — US disclosed
EP-3898576-A1 PREPARATION OF A LYSINATE COMPOUND FROM AN AQUEOUS LYSIN SOLUTION Phytobiotics Futterzusatzstoffe GmbH (DE) 2021-10-27 — — EP disclosed
WO-2020126647-A1 PREPARATION OF A LYSINATE COMPOUND FROM AN AQUEOUS LYSIN SOLUTION PHYTOBIOTICS FUTTERZUSATZSTOFFE GMBH (DE) 2020-06-25 — — WO disclosed
US-20080090297-A1 Methods for determining the metal bioavailability of metal sources NOVUS INTERNATIONAL INC. (US) 2008-04-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220024856-A1 PREPARATION OF A LYSINATE COMPOUND FROM AN AQUEOUS LYSIN SOLUTION LTN1, LCT, LPXN GSR 4803/4885RNPEP 1253/4885GNAI3 4261/4885
US-20260116846-A1 PREPARATION OF A LYSINATE COMPOUND FROM AN AQUEOUS LYSINE SOLUTION SLC6A9, SLC6A19, SLC39A14 GSR 4531/4885RNPEP 1900/4885GNAI3 4664/4885
US-12497350-B2 Preparation of a lysinate compound from an aqueous lysine solution KDM5A, KDM5B, KDM5C GSR 4835/4885RNPEP 1675/4885GNAI3 4543/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback